During the past decade, Emad Zarief Kamel Said conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Emad Zarief Kamel Said" are "Pain, Chronic" (6 trials), "Carpal Tunnel Syndrome" (5 trials), "Postoperative Pain" (4 trials), "Chronic Pain" (3 trials) and "Open Heart Surgery" (2 trials). Many other conditions were trialed in "Emad Zarief Kamel Said" in a lesser frequency.

Most popular intervention types in "Emad Zarief Kamel Said" are "Drug" (24 trials), "Procedure" (9 trials) and "Other" (5 trials). Other intervention types were less common.

The name of intervention was led by "Dexmedetomidine" (3 trials), "Bupivacaine only" (2 trials), "Hyalase" (2 trials), "Ozone" (2 trials) and "Saline" (2 trials). Other intervention names were less common.

The vast majority of trials in "Emad Zarief Kamel Said" are 29 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Emad Zarief Kamel Said". 1 are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 28 completed trials in Emad Zarief Kamel Said, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Emad Zarief Kamel Said, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 31 trials that are defined as “Not Applicable".